Learn more!
Glenn Rice, Ph.D. is a Silicon Valley entrepreneur who has been involved with the start up, financing and building of seven biotech companies as founder/ CEO/ executive management team, which has led to one IPO and a total of four acquisitions (including two by public companies), resulting in significantly enhanced shareholder value.

Currently he is President of MetronomX, Pte. Ltd., a drug company developing clinical therapies for pediatric and adult cancer, and on the board of Pharmacyclics, Inc. (NASDAQ :PCYC) a drug company with four drugs in the clinic for cancer, autoimmune and allergic diseases. As former COO and President of PCYC, he helped to restart the company, redirect the clinical pipeline, and raise $30M from institutional private equity firms and hedge funds. During his tenure the stock price increased 500%. Prior to Pharmacyclics he was CEO and founder of Pacific Biopharma Group Ltd., a firm specializing in US level cGMP biomanufacturing with laboratories in Taizhou, Jiangsu Province, PRC. PBG raised substantial funding from US, Indian, Singapore and China private equity as well as China’s Ministry of Sciences and Technology (MOST). PBG exited into publicly traded PCYC in 2009.

He is the founder and former CEO and President of Bridge Laboratories, Inc. (2004-2007). Bridge is the first company to build and operate FDA compliant pharmaceutical drug development testing laboratories in China (Beijing). Dr. Rice raised $39 million in venture capital funding from US, Taiwan, and Singapore based investors and built the company to 300 employees and revenues of $35 million from two years of start up. He is also currently founder of Emerging Med, Inc. a privately held internet clinical trial prequalification and placement service that connects and manages cancer patients with global clinical trials.

Previously (2002-2004), Dr. Rice headed life sciences at SRI International (Stanford Research Institute- Vice President Biosciences) in Menlo Park

Profile Summary:
Pharmacuetical drug development Burlingame, CA
Operations management Burlingame, CA
science Burlingame, CA
Business Development Burlingame, CA
More About Me
Science, skiing, running, work, travel, writing, politics, family!
Work Experience:
Professional Experience:

2010-cont. President MetronomX Pte. Ltd. Singapore, CA and TX

2009-cont. Director Pharmacyclics (NASDAQ: PCYC)Sunnyvale, CA

2009-2010 COO and President and Director Pharmacyclics, Inc. (NASDAQ: PCYC)Sunnyvale, CA

2007- 2009 CEO and President
Pacific Biopharma Group, Ltd.San Bruno, CA and Taizhou, Jiangsu, China

September 2004-2007 CEO and President Bridge Pharmaceuticals, Inc.
Beijing, P.R.C., San Bruno, CA and Gaithersburg, MD.

February, 2002-2004 Vice President, Biopharmaceutical Division
Stanford Research Institute, (SRI International)Menlo Park, CA

Jul 1999-Aug 2000 Vice President of Research

Jul 1999-Jan 2001 Member of the Board of Directors
Aug 2000- Jan 2002 Vice President Corporate Development ILEX Oncology, Inc. (NASDAQ:ILXO) San Antonio, TX

Jul 99-Present Co-Founder and Chairman of the Board eMergingMed (on line clinical trials prequalification and recruitment and software)
New York, New York

Sept 98-Jul 99 Founder, CEO, President and Chairman of the Board Convergence Pharmaceuticals, Inc.Boston, Massachusetts

1997-1999 Vice President of Research Cytokine Networks, Incorporated
Seattle, WA and S. San Francisco, CA

1992-1996 Program Head, Inflammation Director, Strategic Technical Development(Corporate Officer Level)Cell Therapeutics, Inc. (NASDAQ:CTIC)Seattle, WA

1987 - 1992 Director, Cell Analysis Laboratory Department of Molecular Immunology Genentech, Inc. (NYSE:DNA)
S. San Francisco, CA

1984 - 1987 Director Stanford Core Flow Cytometry Facility Research Associate Cancer Biology Research Laboratory Stanford University Stanford, CA

1983 - 1984 Cancer Research Postdoctoral Fellow Stanford University
Stanford, CA

1981 - 1982 Staff Research Assistant
University of California, San Francisco San Francisco, CA

1978 - 1981 NIH Predoctoral Trainee and Graduate Research Associate, UCSF
Cellular and Molecular Biology, 1983
Radiology and Radiation Biology, 1983
Colorado State University
Fort Collins, Colorado
Dissertation work completed at University of California, San Francisco under mentorship of Dr. Bill Dewey and Joe Gray

Biology/English, 1978
Washington and Jefferson College
Washington, Pennsylvania
Organizations / Affilations:
Professional Organizations:
American Society for Microbiology
American Association for Cancer Research
American Society of Hematology
American Association for Advancement of Science
Genetic and Environmental Toxicological Association
Inflammation Society
Inflammation Research Society
New York Academy of Sciences
American Society of Investigative Pathology
International Society for Analytical Cytology
Lincoln Club
New Majority
Rotary Club
Glenn Rice is located in Burlingame, CA and has the following skills: Pharmacuetical drug development, Operations management, science, Business Development
Business, Technology
Similar Skillwho Members
My Skills

Pharmacuetical drug development

Category: Business
I develop innovative biopharmaceutical drugs for the US, EU, JP and PRC markets. This involves discovery, development,manufacturing, formulation clinical testing, and regulatory approval
Relevant Education / Credentials
PH.D. in Molecular and Cellular Biology and Radiology and Radiation Biology at Colorado State University; Post doctoral fellow and Researcher at Stanford University
Years Experience: 30

Operations management

Category: Business
Acting as a chief operating officer with oversight on all of the above functions
Relevant Education / Credentials
Many years as a 'turn around' specialist for distressed companies and institutes.
Years Experience: 15


Category: Technology
Preclinical development of lead compounds based on inhibition of a specific molecular target.
Relevant Education / Credentials
Many successful years of undertaking
Years Experience: 30

Business Development

Category: Business
In license and out license of drug development rights for an aggregrate of billion plus dollars; also merger and acquisition and IPO and reverse IPO experience. Also experience raising hundreds of millions of private and public equity.
Relevant Education / Credentials
Track record at CTIC, Convergence, Cytokine Networks, SRI, ILEX, Bridge, PBG, and Pharmacyclics
Years Experience: 30